ReviewTherapeutic advances in vaccines and immunotherapy2018

Optimal use of meningococcal serogroup B vaccines: moving beyond outbreak control.

Paul Balmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.